FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014308927> ?p ?o ?g. }

• W2014308927 endingPage "253" @default.
• W2014308927 startingPage "244" @default.
• W2014308927 abstract "Aim: Kinin B1 receptor (B1R) contributes to insulin resistance through a mechanism involving oxidative stress. This study examined the effect of B1R blockade on the changes in plasma fatty acids composition, body and tissue fat mass and adipose tissue inflammation that influence insulin resistance. Methods: Sprague–Dawley rats were fed with 10% D-glucose or tap water (Control) for 13 weeks and during the last week, rats were administered the B1R antagonist SSR240612 (10 mg/kg/day, gavage) or vehicle. The following parameters were assessed: plasma fatty acids (by gas chromatography), body composition (by EchoMRI), metabolic hormone levels (by radioimmunoassay), expression of B1R and inflammatory markers in adipose tissue (by Western blot and qRT-PCR). Results: Glucose feeding significantly increased plasma levels of glucose, insulin, leptin, palmitoleic acid (16:1n-7), oleic acid (18:1n-9), Δ6 and Δ9 desaturases while linoleic acid (18:2n-6), arachidonic acid (20:4n-6) and Δ5 desaturase were decreased. SSR240612 reduced plasma levels of insulin, glucose, the homeostasis model assessment index of insulin resistance, palmitoleic acid and n-7 family. Alterations of Δ5, Δ6 and Δ9 desaturases were normalized by SSR240612. The B1R antagonist also reversed the enhancing effect of glucose feeding on whole body and epididymal fat mass and on the expression of macrophage CD68, interleukin-1β, tumour necrosis factor-α and inducible nitric oxide synthase in retroperitoneal adipose tissue. B1R protein and mRNA were not detected in retroperitoneal adipose tissue. Conclusion: Insulin resistance in glucose-fed rats is associated with low state inflammation in adipose tissue and plasma fatty acids changes which are reversed by B1R blockade. These beneficial effects may contribute to insulin sensitivity improvement and the prevention of obesity." @default.
• W2014308927 created "2016-06-24" @default.
• W2014308927 creator A5026903265 @default.
• W2014308927 creator A5047217675 @default.
• W2014308927 date "2011-11-21" @default.
• W2014308927 modified "2023-10-18" @default.
• W2014308927 title "Blockade of kinin B1 receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance" @default.
• W2014308927 cites W1494780959 @default.
• W2014308927 cites W1520604801 @default.
• W2014308927 cites W1966842587 @default.
• W2014308927 cites W1974218877 @default.
• W2014308927 cites W1977685141 @default.
• W2014308927 cites W1987608585 @default.
• W2014308927 cites W1989471394 @default.
• W2014308927 cites W1991861144 @default.
• W2014308927 cites W1991983815 @default.
• W2014308927 cites W1993540550 @default.
• W2014308927 cites W1996165509 @default.
• W2014308927 cites W1999540978 @default.
• W2014308927 cites W2001143541 @default.
• W2014308927 cites W2004346418 @default.
• W2014308927 cites W2008738296 @default.
• W2014308927 cites W2011923274 @default.
• W2014308927 cites W2016384861 @default.
• W2014308927 cites W2018484907 @default.
• W2014308927 cites W2019009753 @default.
• W2014308927 cites W2023032026 @default.
• W2014308927 cites W2027375835 @default.
• W2014308927 cites W2030778616 @default.
• W2014308927 cites W2043250246 @default.
• W2014308927 cites W2045246923 @default.
• W2014308927 cites W2048979235 @default.
• W2014308927 cites W2061873998 @default.
• W2014308927 cites W2072963414 @default.
• W2014308927 cites W2073049822 @default.
• W2014308927 cites W2076691452 @default.
• W2014308927 cites W2091588586 @default.
• W2014308927 cites W2096048424 @default.
• W2014308927 cites W2097030097 @default.
• W2014308927 cites W2107971415 @default.
• W2014308927 cites W2115177689 @default.
• W2014308927 cites W2115565372 @default.
• W2014308927 cites W2123814639 @default.
• W2014308927 cites W2124821727 @default.
• W2014308927 cites W2125058279 @default.
• W2014308927 cites W2129316761 @default.
• W2014308927 cites W2131953091 @default.
• W2014308927 cites W2138934442 @default.
• W2014308927 cites W2142699432 @default.
• W2014308927 cites W2150367899 @default.
• W2014308927 cites W2152037832 @default.
• W2014308927 cites W2152377123 @default.
• W2014308927 cites W2158737769 @default.
• W2014308927 cites W2160234571 @default.
• W2014308927 cites W2162846451 @default.
• W2014308927 cites W2168393830 @default.
• W2014308927 cites W2170239577 @default.
• W2014308927 cites W2172279710 @default.
• W2014308927 cites W2185289178 @default.
• W2014308927 cites W2211467290 @default.
• W2014308927 cites W2336670769 @default.
• W2014308927 cites W4233409187 @default.
• W2014308927 cites W4249727000 @default.
• W2014308927 doi "https://doi.org/10.1111/j.1463-1326.2011.01521.x" @default.
• W2014308927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22023455" @default.
• W2014308927 hasPublicationYear "2011" @default.
• W2014308927 type Work @default.
• W2014308927 sameAs 2014308927 @default.
• W2014308927 citedByCount "28" @default.
• W2014308927 countsByYear W20143089272012 @default.
• W2014308927 countsByYear W20143089272013 @default.
• W2014308927 countsByYear W20143089272014 @default.
• W2014308927 countsByYear W20143089272015 @default.
• W2014308927 countsByYear W20143089272016 @default.
• W2014308927 countsByYear W20143089272017 @default.
• W2014308927 countsByYear W20143089272019 @default.
• W2014308927 countsByYear W20143089272020 @default.
• W2014308927 countsByYear W20143089272022 @default.
• W2014308927 crossrefType "journal-article" @default.
• W2014308927 hasAuthorship W2014308927A5026903265 @default.
• W2014308927 hasAuthorship W2014308927A5047217675 @default.
• W2014308927 hasConcept C126322002 @default.
• W2014308927 hasConcept C134018914 @default.
• W2014308927 hasConcept C151955695 @default.
• W2014308927 hasConcept C171089720 @default.
• W2014308927 hasConcept C185592680 @default.
• W2014308927 hasConcept C2777391703 @default.
• W2014308927 hasConcept C2779306644 @default.
• W2014308927 hasConcept C2779641957 @default.
• W2014308927 hasConcept C2780809830 @default.
• W2014308927 hasConcept C543025807 @default.
• W2014308927 hasConcept C55493867 @default.
• W2014308927 hasConcept C71924100 @default.
• W2014308927 hasConcept C86803240 @default.
• W2014308927 hasConceptScore W2014308927C126322002 @default.
• W2014308927 hasConceptScore W2014308927C134018914 @default.
• W2014308927 hasConceptScore W2014308927C151955695 @default.
• W2014308927 hasConceptScore W2014308927C171089720 @default.

• next